Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by Looking4Doubleson Mar 21, 2020 9:03am
58 Views
Post# 30833050

🤡 🤡 Clown Alert: Canuckguy420 is a trapped SHORT 🤡 🤡

🤡 🤡 Clown Alert: Canuckguy420 is a trapped SHORT 🤡 🤡Over the last 8 months, "IT" has repeatedly lied and bashed this stock board in a FUTILE attempt at coercing investors into selling their stock to " IT"   

" IT " has used over 60 screen names to lie, impersonate, haraass and mislead investors knowing that:

1.) " IT " is TRAPPED and has NO options left &
2.) Time is QUICKLY running out on " IT'S position and "IT" KNOWS IT ! ! !  ha ha ha

Bassa and his Israeli banker friends will crush IT shortly ! !

IGNORE AND REPORT TO STOCKHOUSE / AUTHORITIES / SEC
Bullboard Posts